김은지, 2018 - Google Patents
Studies on the Potential Probiotic Strains Isolated from Korean Traditional Fermented Foods for Alleviating the Intestinal Inflammation김은지, 2018
View PDF- Document ID
- 1141150367052106791
- Author
- 김은지
- Publication year
External Links
Snippet
Inflammatory bowel disease (IBD) including ulcerative colitis and crohns disease is caused by chronic inflammation in the digestive tract. Even though the exact pathogenesis remains unclear, dysbiosis of gut microbiota, damage of epithelial integrity, imbalance of cytokine …
- 239000006041 probiotic 0 title abstract description 55
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—PROCESSES USING MICRO-ORGANISMS
- C12R1/00—Processes using micro-organisms
- C12R1/01—Processes using micro-organisms using bacteria or actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23Y—INDEXING SCHEME RELATING TO LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23Y2220/00—Lactobacillus
- A23Y2220/73—Rhamnosus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using micro-organisms or enzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Plaza-Diaz et al. | Mechanisms of action of probiotics | |
| de Melo Pereira et al. | How to select a probiotic? A review and update of methods and criteria | |
| Sashihara et al. | An analysis of the effectiveness of heat-killed lactic acid bacteria in alleviating allergic diseases | |
| Zoumpopoulou et al. | Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models | |
| US10272122B2 (en) | Lactobacillus plantarum inducia DSM 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against Clostridium difficile | |
| Caselli et al. | Actual concept of" probiotics": is it more functional to science or business? | |
| WO2022218335A1 (en) | Lactobacillus reuteri, and use, composition, drug and food thereof | |
| Leahy et al. | Getting better with bifidobacteria | |
| Reiff et al. | Inflammatory bowel disease, gut bacteria and probiotic therapy | |
| US7927584B2 (en) | Lactic bacteria useful as probiotics | |
| BR112012011315B1 (en) | Formulation comprising probiotic bifidobacteria strain | |
| AU2011340460A1 (en) | Bifidobacterium CECT 7765 and use thereof in the prevention and/or treatment of excess weight, obesity and related pathologies | |
| CN105555283B (en) | Probiotic for excessive crying of infants | |
| Zaib et al. | Probiotics and their beneficial health effects | |
| Mansour et al. | Inhibition of Clostridium difficile in mice using a mixture of potential probiotic strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015: novel candidates to control C. difficile infection (CDI) | |
| Tellez et al. | A peptidic fraction from milk fermented with Lactobacillus helveticus protects mice against Salmonella infection | |
| EP2220210B1 (en) | Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect | |
| Gregoret et al. | A comprehensive approach to determine the probiotic potential of human-derived Lactobacillus for industrial use | |
| Kesen et al. | Beneficial characteristics and evaluation criteria of probiotics | |
| Kılıç et al. | Identification of lactic acid bacteria isolated from the fecal samples of healthy humans and patients with dyspepsia, and determination of their pH, bile, and antibiotic tolerance properties | |
| Hickson | Examining the evidence for the use of probiotics in clinical practice | |
| JP7358001B2 (en) | Lactic acid bacteria, interleukin-22 production inducer, skin barrier function enhancer | |
| Kumar et al. | Bifidobacteria for life betterment | |
| Patra et al. | Determination and safety aspects of probiotic cultures | |
| Sherwani | Probiotics in processed dairy products and their role in gut microbiota health |